“…As a stealth pathogen, Bbsl slips by host defenses and sequesters in deep-seated tissue (i.e., ligaments, tendons, bone, eye, brain, muscle, glial and neuronal cells, synovium, and scar tissue) [68,69,70,71,72,73,74,75,76,77,78,79]. The persistence of Bbsl in chronic Lyme disease patients is well documented [4,80,81]. In the advanced stage, patients can have cognitive impairment that results in a gradually developing spectrum of neuropsychiatric symptoms [82,83].…”